PI3K/GSKβ/c-Myc is crucial for pancreatic cancer cell cycle progression.187 GSKβ inhibition decreases the expression of NF-κB and NF-κB -mediated expression of c-Myc in pancreatic cancer, thereby reducing tumor growth.188. The gene discussed is MYC; the disease is pancreatic neoplasm.